Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Assessment of bone marrow (BM) involvement in peripheral T-cell lymphoma, not otherwise specified (PTCL) is straightforward in cases of extensive involvement but difficult in cases of minimal to partial involvement. We evaluated the usefulness of CD3 as an immunohistochemical marker for assessing BM involvement in PTCL patients. BM biopsies of 92 PTCL patients were immunohistochemically stained for CD3, CD4, CD8, CD20, and CD56, and evaluated by two hematopathologists. CD3 positivity was graded according to the proportion of CD3-positive cells and the number of CD3-positive cells in a cluster. These criteria were used to determine the cut-offs at which significant differences in progression-free survival (PFS) and overall survival (OS) were observed. Multivariate analysis controlling the International Prognostic Index (IPI) score and its individual factors revealed that >20 CD3-positive cells in a cluster adversely affected PFS (relative risk [RR], 2.1; 95% confidence interval [CI], 1.0–4.3; P=0.047) and OS (RR, 2.4; 95% CI, 1.1–5.1; P=0.028) independent of IPI score. A cluster with >20 CD3-positive cells is a candidate indicator for BM involvement in PTCL.
Abstract
Assessment of bone marrow (BM) involvement in peripheral T-cell lymphoma, not otherwise specified (PTCL) is straightforward in cases of extensive involvement but difficult in cases of minimal to partial involvement. We evaluated the usefulness of CD3 as an immunohistochemical marker for assessing BM involvement in PTCL patients. BM biopsies of 92 PTCL patients were immunohistochemically stained for CD3, CD4, CD8, CD20, and CD56, and evaluated by two hematopathologists. CD3 positivity was graded according to the proportion of CD3-positive cells and the number of CD3-positive cells in a cluster. These criteria were used to determine the cut-offs at which significant differences in progression-free survival (PFS) and overall survival (OS) were observed. Multivariate analysis controlling the International Prognostic Index (IPI) score and its individual factors revealed that >20 CD3-positive cells in a cluster adversely affected PFS (relative risk [RR], 2.1; 95% confidence interval [CI], 1.0–4.3; P=0.047) and OS (RR, 2.4; 95% CI, 1.1–5.1; P=0.028) independent of IPI score. A cluster with >20 CD3-positive cells is a candidate indicator for BM involvement in PTCL.
참고문헌 (13)
- Savage KJ, "Update : peripheral T-cell lymphomas", Curr Hematol Malig Rep, 6, pp.222~230 (2011)
- Delmer A, "Peripheral T-cell malignant lymphomas. Clinical, morphologic and developmental features in 22 cases", Presse Med, 19, pp.851~855 (1990)
- Chott A, "Peripheral T-cell lymphomas : a clinicopathologic study of 75 cases", Hum Pathol, 21, pp.1117~1125 (1990)
- Gisselbrecht C, "Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA)", Blood, 92, pp.76~82 (1998)
- López-Guillermo A, "Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification", Ann Oncol, 9, pp.849~855 (1998)
- Dogan A, "Bone marrow histopathology in peripheral T-cell lymphomas", Br J Haematol, 127, pp.140~154 (2004)
- Carbone PP, "Report of the committee on Hodgkin’s disease staging classification", Cancer Res, 31, pp.1860~1861 (1971)
- Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5, pp.649~655 (1982)
- The International Non-Hodgkin’s Lymphoma Prognostic Factors Project, "A predictive model for aggressive non-Hodgkin’s lymphoma", N Engl J Med, 329, pp.987~994 (1993)
- Gallamini A, "Peripheral T-cell lymphoma unspecified(PTCL-U) : a new prognostic model from a retrospective multicentric clinical study", Blood, 103, pp.2474~2479 (2004)
- Falini B, "Peripheral T-cell lymphoma associated with hemophagocytic syndrome", Blood, 75, pp.434~444 (1990)
- Rao SA, "T cell lymphoma associated with myelofibrosis", Leuk Lymphoma, 44, pp.715~718 (2003)
- Weisenburger DD, "Peripheral T-cell lymphoma, not otherwise specified : a report of 340 cases from the International Peripheral T-cell Lymphoma Project", Blood, 117, pp.3402~3408 (2011)